Pfizer (NYSE:PFE) has been dismissed as a defendant in a major federal lawsuit alleging generic drug price fixing. The court ...
Demand for GLP-1 drugs such as semaglutide is exposing capacity gaps across peptide APIs, sterile fill-finish facilities, ...
FDA takes an industry-friendly approach; Trump aide in consideration to lead FDA; Biotech CEOs are suddenly bullish.
Dr Reddy's whitepaper says weak translational research ecosystem is slowing the journey from laboratory breakthroughs to ...
Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it ...
Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it ...
Teens increasingly have mental health issues, schools are trying to keep up. School psychologists are costly. LLMs can be an ...
"The Orphan Designation for ODM-212 is an important milestone for Orion Pharma. It highlights the need for new treatments in mesothelioma and reinforces our commitment to developing innovative ...
When Matt Conway tore his bicep delivering a table recently, there were numerous barriers to getting it fixed. First, “a ...
Cipla, Reliance, Voltas, RVNL and Bharat Forge dominated midday trade as Jio IPO progress, fresh orders and EV wins drove ...
The Mission Biopharma SHAKTI scheme, launched in 2026-27, marks an important step in promoting biologics and biosimilars ...
EEST Orion Pharma's ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission Orion Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results